Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults

Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age6+
SponsorChildren's Hospital Medical Center, Cincinnati

About this trial

The goal of this study is to evaluate the usefulness of hyperpolarized (HP) 129Xe (xenon) gas MRI for regional assessment of lung function in a normal population of children and adults and in adults and also in children with respiratory compromise due to a variety of diseases.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Ages 6 and up

Participant must be able to hold breath for up to 16 seconds

Disqualifiers

History of heart defect

Pregnancy or positive pregnancy test

History of uncontrolled asthma defined for this study as requiring use of rescue inhaler ≥ 2 times in past month

Symptoms of respiratory infection (loose or productive cough or wheeze), chest tightness, or sinus infection within past week

Trial design

Design model

Single group

Treatments tested in this trial

  • Hyperpolarized 129 Xenon

    Drug

    During the scans, subject will inhale hyperpolarized Xenon gas for up to 16 seconds per scan, for up to 4 separate MR scans

Treatment groups

300 Participants
are divided into 1 treatment group
Group A: Hyperpolarized 129 XenonExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Correlation of ventilated volume predictions obtained with 129Xe MRI vs. 1H MRI

quantify the measurement agreement between the ventilated volume of healthy lungs predicted via 129 Xe MRI and the ventilated volume of the pleural cavity predicted via proton MRI

Time frame
Day 1

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.